James C Czirr insider trades: Galectin Therapeutics (GALT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | GALT | ↓ Sell | 30,681 | $6.66 | $204K | Direct | Dec 18, 2025 (2d) |
| Dec 3, 2025 | GALT | ↓ Sell | 150,000 | $5.68 | $852K | Direct | Dec 4, 2025 (1d) |
| Nov 11, 2025 | GALT | ↓ Sell | 40,000 | $5.25 | $210K | Direct | Nov 12, 2025 (1d) |
| Oct 22, 2025 | GALT | ↓ Sell | 50,000 | $4.94 | $247K | Direct | Oct 24, 2025 (2d) |
| Apr 23, 2024 | GALT | ↓ Sell | 25,000 | $3.06 | $77K | By 10X Fund, LP | Apr 25, 2024 (2d) |
| Jul 22, 2022 | GALT | ↓ Sell | 10,000 | $2.09 | $21K | Direct | Aug 9, 2022 (18d) |
| Feb 2, 2022 | GALT | ↓ Sell | 10,000 | $2.10 | $21K | Direct | Feb 4, 2022 (2d) |
| Jan 11, 2022 | GALT | ↓ Sell | 10,000 | $2.10 | $21K | Direct | Jan 13, 2022 (2d) |
| Dec 2, 2021 | GALT | ↓ Sell | 10,000 | $2.37 | $24K | Direct | Dec 6, 2021 (4d) |
| Nov 1, 2021 | GALT | ↓ Sell | 10,000 | $3.19 | $32K | Direct | Nov 4, 2021 (3d) |
| Oct 15, 2021 | GALT | ↓ Sell | 10,000 | $3.37 | $34K | Direct | Oct 19, 2021 (4d) |
| Oct 4, 2021 | GALT | ↓ Sell | 10,000 | $3.62 | $36K | Direct | Oct 6, 2021 (2d) |
| Sep 1, 2021 | GALT | ↓ Sell | 10,000 | $3.91 | $39K | Direct | Sep 3, 2021 (2d) |
| Aug 2, 2021 | GALT | ↓ Sell | 10,000 | $3.25 | $33K | Direct | Aug 3, 2021 (1d) |
| Jul 9, 2021 | GALT | ↓ Sell | 10,000 | $3.54 | $35K | Direct | Jul 15, 2021 (6d) |
| Jun 1, 2021 | GALT | ↓ Sell | 10,000 | $3.91 | $39K | Direct | Jun 3, 2021 (2d) |
| May 3, 2021 | GALT | ↓ Sell | 27,500 | $3.97 | $109K | Direct | May 4, 2021 (1d) |
| Apr 1, 2021 | GALT | ↓ Sell | 10,000 | $2.16 | $22K | Direct | Apr 5, 2021 (4d) |
| Mar 1, 2021 | GALT | ↓ Sell | 10,000 | $2.31 | $23K | Direct | Mar 4, 2021 (3d) |
| Feb 2, 2021 | GALT | ↓ Sell | 10,000 | $2.04 | $20K | Direct | Feb 5, 2021 (3d) |
| Jan 4, 2021 | GALT | ↓ Sell | 10,000 | $2.23 | $22K | Direct | Jan 5, 2021 (1d) |
| Oct 13, 2020 | GALT | ↓ Sell | 10,000 | $2.97 | $30K | Direct | Oct 15, 2020 (2d) |
| Jan 17, 2020 | GALT | ↓ Sell | 10,000 | $2.97 | $30K | Direct | Jan 21, 2020 (4d) |
| Oct 10, 2019 | GALT | ↓ Sell | 17,000 | $3.73 | $63K | Direct | Oct 15, 2019 (5d) |
| Jun 18, 2018 | GALT | ↓ Sell10b5-1 | 151,860 | $8.61 | $1.3M | Indirect | Jun 20, 2018 (2d) |
| Jun 13, 2018 | GALT | ↓ Sell10b5-1 | 208,140 | $7.17 | $1.5M | Indirect | Jun 14, 2018 (1d) |
| Jun 8, 2018 | GALT | ↓ Sell10b5-1 | 110,000 | $5.88 | $647K | Indirect | Jun 12, 2018 (4d) |
| Jun 4, 2018 | GALT | ↓ Sell | 50,000 | $5.12 | $256K | Indirect | Jun 5, 2018 (1d) |
| Jan 26, 2018 | GALT | ↓ Sell | 244,444 | $5.43 | $1.3M | See Footnore | Jan 29, 2018 (3d) |
| Apr 20, 2016 | GALT | ↓ Sell | 44,312 | $1.67 | $74K | By 10X Fund, L.P. | Apr 21, 2016 (1d) |
| Jan 13, 2014 | GALT | ↓ Sell | 100,000 | $14.84 | $1.5M | By 10X Fund, L.P. | Jan 14, 2014 (1d) |
| Nov 15, 2013 | GALT | ↑ Buy | 1,000 | $6.90 | $7K | Direct | Nov 18, 2013 (3d) |
| Oct 8, 2013 | GALT | ↓ Sell | 112,000 | $11.85 | $1.3M | By 10X Fund, L.P. | Oct 9, 2013 (1d) |
| May 17, 2012 | GALT | ↑ Buy | 10,000 | $2.25 | $23K | Direct | May 18, 2012 (1d) |
| Jan 21, 2009 | PRWP.OB | ↓ Sell | 250,000 | $0.08 | $20K | Direct | Feb 25, 2009 (35d) |
| Jul 10, 2006 | PRW | ↓ Sell | 5,000 | $3.00 | $15K | Direct | Jul 11, 2006 (1d) |
| Jul 7, 2006 | PRW | ↓ Sell | 10,000 | $2.65 | $27K | Direct | Jul 11, 2006 (4d) |
| Jun 12, 2006 | PRW | ↓ Sell | 20,000 | $3.25 | $65K | Direct | Jun 13, 2006 (1d) |
| Jun 1, 2006 | PRW | ↓ Sell | 20,000 | $3.22 | $64K | Direct | Jun 5, 2006 (4d) |
| May 3, 2006 | PRW | ↓ Sell | 20,000 | $3.28 | $66K | Direct | May 4, 2006 (1d) |
| Apr 3, 2006 | PRW | ↓ Sell | 20,000 | $3.93 | $79K | Direct | Apr 5, 2006 (2d) |
| Mar 1, 2006 | PRW | ↓ Sell | 40,000 | $3.30 | $132K | Direct | Mar 2, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GALT insiders
Open-market trades in the last 12 months
About James C Czirr's insider trades
James C Czirr is a 10% owner of Galectin Therapeutics (GALT). Since Mar 1, 2006, James has reported 2 open-market purchases worth $29K and 40 sales worth $10.6M on SEC Form 4. In the last 12 months: 3 sales ($1.3M).
3 sales (32% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include other transactions (24 filings), grants and awards (17 filings), option exercises (7 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GALT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.